peptide-based vaccines (BTGC/Yeda)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namepeptide-based vaccines (BTGC/Yeda)
Drug Alias Namecancer vaccines (BTGC/Yeda)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder NeoplasmsColonic NeoplasmsBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWeizmann Institute Of Science
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWeizmann Institute Of ScienceSavient Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsUrinary Bladder NeoplasmsColonic NeoplasmsBreast Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A